NCT01550718

Brief Summary

Alzheimer's disease (AD) is increasing exponentially, with a projected quadrupling of cases by the mid 21st century. Individuals with AD are at increased risk for a host of medical and psychiatric conditions, and evidence is accumulating supporting the efficacy and effectiveness of psychosocial interventions for improving their mood, function, health, and quality of life. Such interventions are likely to be most effective when they are implemented during the early stages of dementia, when individuals and their family members are coping with the initial diagnosis and associated changes in abilities and activities. Recent randomized clinical trials by the Principal Investigator and colleagues have developed two non-pharmacologic interventions to reduce the social, psychological, physical, and behavioral impact of dementia. This investigation is focused on facilitating their translation into ongoing community-based programs, such as those provided by Alzheimer's Association chapters, senior centers, retirement homes, and other health care providers. The core content of each intervention has been retained in order to maintain or improve their efficacy, and each has been modified to a 4-week group format to increase efficiency of delivery. These modified interventions (ESML-Social and ESML-Ex) will be compared to each other and to a usual care (UC) control group. Outcomes will be assessed at baseline, 1-month post treatment, and 4 month follow-up. Primary outcomes at the 1-month assessment include: social activity participation, family communication, physical activity participation, and physical function. Primary outcomes at 4-month follow up include overall quality of life and depression. It is hypothesized that ESML-Ex and ESML-Social both will have greater improvements than UC. It is hypothesized that ESML-Social will have greater improvements in social participation and family communication than ESML-Ex and UC. It is hypothesized that ESML-Ex will have greater improvements in physical activity participation and physical functioning than ESML-Social and UC. If successful, these 4-week programs may be developed into "modules" that can be incorporated into programming for individuals with early stage dementia in a variety of community settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 5, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 12, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

June 10, 2015

Status Verified

June 1, 2015

Enrollment Period

3 years

First QC Date

March 5, 2012

Last Update Submit

June 8, 2015

Conditions

Keywords

Aerobic ExerciseAlzheimer's DiseaseBurden and StressCaregiving IssuesQuality of LifeEarly Stage Memory Loss

Outcome Measures

Primary Outcomes (6)

  • Change from Baseline in Social Activity at post-treatment (1 month)

    The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.

    Baseline and post treatment (1 month)

  • Change from Baseline in Physical Activity at post-treatment (1 month)

    The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.

    Baseline and post-treatment (1 month)

  • Change from Baseline in Quality of Life at post-treatment (1 month)

    The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.

    Baseline and post treatment (1 month)

  • Change from Baseline in Social Activity at 4 month follow-up

    The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.

    Baseline and 4 month follow-up

  • Change from Baseline in Physical Activity at 4 month follow-up

    The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.

    Baseline and 4 month follow-up

  • Change from Baseline in Quality of Life at 4 month follow-up

    The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.

    Baseline and 4 month follow-up

Secondary Outcomes (6)

  • Change from Baseline in Communication at post-treatment (1 month)

    Baseline and post treatment (1 month)

  • Change from Baseline in Physical Function at post-treatment (1 month)

    Baseline and post treatment (1 month)

  • Change from Baseline in Mood at post-treatment (1 month)

    Baseline and post-treatment (1 month)

  • Change from Baseline in Communication at post-treatment (1 month)

    Baseline and post-treatment (1 month)

  • Change from Baseline in Physical Functioning at post-treatment (1 month)

    Baseline and post-treatment (1 month)

  • +1 more secondary outcomes

Study Arms (3)

ESML-Exercise (Physical Activity Program)

ACTIVE COMPARATOR

ESML-Exercise consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic. Classes are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the class gets individual attention and that all exercises are done safely using proper form.

Behavioral: ESML-EX (Physical Activity Program)

ESML-SOCIAL (Social Activity Program)

ACTIVE COMPARATOR

ESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session. Seminars are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the seminar gets individual attention and that everyone has a chance to bring up any concerns.

Behavioral: ESML-Social (Social Activity Program)

No Intervention

NO INTERVENTION

This arm will receive no intervention during the active treatment period. After the 4 month assessment participants can choose to attend a support group.

Interventions

ESML-EX consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic.

ESML-Exercise (Physical Activity Program)

ESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session.

ESML-SOCIAL (Social Activity Program)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dementia diagnosis
  • Clinical Dementia Rating Scale score
  • Care Partner agrees to participate with care recipient
  • Care recipient lives in the community or a retirement home
  • Both care partner and recipient speak English

You may not qualify if:

  • Significant physical or psychiatric illness in either care partner or care recipient that would prevent participant in a exercise program
  • Planning to move out of study area during the 4 month follow-up period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UWashington

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

DementiaAlzheimer Disease

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative Diseases

Study Officials

  • Rebecca G Logsdon, Ph.D.

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Professor

Study Record Dates

First Submitted

March 5, 2012

First Posted

March 12, 2012

Study Start

February 1, 2012

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

June 10, 2015

Record last verified: 2015-06

Locations